G Boman, A S Malmborg. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultAgedDose-Response Relationship, DrugFemaleHalf-LifeHumansImmunodiffusionMaleMiddle AgedPleural Effusion/metabolismProteins/metabolismRegression AnalysisRifampin/bloodRifampin/metabolismRifampin/pharmacologySarcina/drug effectsTime Factors
Substances: See more » ProteinsRifampin
Year: 1974 PMID: 4212324 DOI: 10.1007/bf00614390
Source DB: PubMed Journal: Eur J Clin Pharmacol ISSN: 0031-6970 Impact factor: 2.953